BioCryst Pharmaceuticals BCRX Cash, Cash Equivalents, and Marketable Securities
Cash, Cash Equivalents, and Marketable Securities at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
As of June 30, 2026, the Company had 25 securities with a total estimated fair value of $185,122 in an unrealized loss position. The unrealized losses were primarily attributable to changes in market interest rates and not to deterioration in the credit quality of the issuers. The Company does not have an intent to sell these investments, and it is more likely than not that the investments will be held until recovery of their amortized cost basis. As such, no allowance was recognized.
Item 1. Financial Statements (Unaudited):
FAQ
- What is BioCryst Pharmaceuticals's cash, cash equivalents, and marketable securities?
- BioCryst Pharmaceuticals (BCRX) reported cash, cash equivalents, and marketable securities of $185.12M in Q2 2026.
- How has BioCryst Pharmaceuticals's cash, cash equivalents, and marketable securities changed year-over-year?
- BioCryst Pharmaceuticals's cash, cash equivalents, and marketable securities increased by 213.1% year-over-year, from $59.12M to $185.12M.
- What does cash, cash equivalents, and marketable securities mean?
- This represents the most liquid assets held by the company, including cash on hand, bank deposits, and short-term investments that can be readily converted into cash. It serves as the primary buffer for operational liquidity and potential capital allocation activities. Investors monitor this to assess the company's ability to meet short-term obligations and fund growth initiatives.
Ask your AI about BioCryst Pharmaceuticals's cash, cash equivalents, and marketable securities.
Connect your AI assistant and compare it to peers, right in your chat.
